Total Payments
$4,529
2024 Payments
$98.13
Companies
17
Transactions
138
Medicare Patients
1,561
Medicare Billing
$143,902
Payment Breakdown by Category
Food & Beverage$4,517 (99.7%)
Education$12.80 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,517 | 135 | 99.7% |
| Education | $12.80 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $2,193 | 66 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $590.84 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $548.42 | 13 | $0 (2023) |
| AbbVie Inc. | $310.24 | 7 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $289.38 | 16 | $0 (2019) |
| Edwards Lifesciences Corporation | $135.64 | 2 | $0 (2022) |
| Inspire Medical Systems, Inc. | $99.22 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $94.52 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $92.32 | 4 | $0 (2024) |
| Amgen Inc. | $33.75 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.13 | 4 | AstraZeneca Pharmaceuticals LP ($30.34) |
| 2023 | $548.73 | 12 | Gilead Sciences, Inc. ($246.29) |
| 2022 | $512.54 | 13 | Gilead Sciences, Inc. ($279.01) |
| 2021 | $141.92 | 7 | Gilead Sciences, Inc. ($62.21) |
| 2020 | $242.01 | 9 | Gilead Sciences, Inc. ($178.72) |
| 2019 | $907.69 | 36 | Gilead Sciences, Inc. ($467.59) |
| 2018 | $945.49 | 22 | Gilead Sciences, Inc. ($333.91) |
| 2017 | $1,133 | 35 | Gilead Sciences Inc ($603.32) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.39 | General |
| 05/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: DIABETES | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Cardiology | ||||||
| 10/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: DIABETES | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $117.07 | General |
| Category: HBV | ||||||
| 06/17/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: VACCINES | ||||||
| 04/27/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.72 | General |
| 03/22/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $103.50 | General |
| 03/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: DIABETES | ||||||
| 02/23/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $99.22 | General |
| Category: NEUROLOGY | ||||||
| 02/17/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Cardiovascular | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.41 | General |
| 10/26/2022 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 08/26/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Cardiovascular | ||||||
| 06/10/2022 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), MENQUADFI | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Vaccines | ||||||
| 05/05/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.18 | General |
| 03/16/2022 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $134.64 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/16/2022 | Edwards Lifesciences Corporation | — | Education | In-kind items and services | $1.00 | General |
| 03/10/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.39 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 444 | 734 | $116,050 | $38,929 |
| 2022 | 4 | 507 | 1,035 | $129,720 | $51,566 |
| 2021 | 4 | 414 | 785 | $86,300 | $41,983 |
| 2020 | 4 | 196 | 281 | $30,750 | $11,423 |
Total Patients
1,561
Total Services
2,835
Medicare Billing
$143,902
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 192 | $38,400 | $13,144 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 205 | $36,900 | $9,769 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 55 | 55 | $13,750 | $8,575 | 62.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 131 | 255 | $22,950 | $5,832 | 25.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 25 | 27 | $4,050 | $1,609 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 235 | $39,850 | $16,203 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 81 | 81 | $13,350 | $12,187 | 91.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 269 | $36,020 | $11,596 | 32.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 166 | 450 | $40,500 | $11,581 | 28.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 189 | $28,350 | $15,742 | 55.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 152 | 351 | $31,590 | $10,324 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 114 | 206 | $20,510 | $10,067 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 39 | 39 | $5,850 | $5,850 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 70 | $10,500 | $4,559 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $3,150 | $2,982 | 94.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 77 | $6,930 | $2,816 | 40.6% |
| G2061 | Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes | Office | 2020 | 69 | 113 | $10,170 | $1,067 | 10.5% |
About Dr. Dung Phan, MD
Dr. Dung Phan, MD is a Family Medicine healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912013780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dung Phan, MD has received a total of $4,529 in payments from pharmaceutical and medical device companies, with $98.13 received in 2024. These payments were reported across 138 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,517).
As a Medicare-enrolled provider, Phan has provided services to 1,561 Medicare beneficiaries, totaling 2,835 services with total Medicare billing of $143,902. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location San Jose, CA
- Active Since 08/22/2006
- Last Updated 07/13/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912013780
Products in Payments
- Vemlidy (Drug) $1,489
- Vascepa (Drug) $548.42
- FARXIGA (Drug) $452.45
- BEVESPI AEROSPHERE (Drug) $138.39
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $134.64
- SEEBRI (Drug) $110.65
- Mavyret (Drug) $108.81
- INSPIRE (Device) $99.22
- JARDIANCE (Drug) $92.32
- LONHALA MAGNAIR (Drug) $83.73
- Creon (Drug) $71.17
- AREXVY (Drug) $68.06
- Repatha (Biological) $33.75
- RYBELSUS (Drug) $32.79
- BEXSERO (Biological) $26.46
- ZENPEP (Drug) $24.97
- BREATHTEK (Device) $19.77
- INVOKANA (Drug) $18.88
- JANUVIA (Drug) $15.72
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $14.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in San Jose
Milton Mccoll, M.d, M.D
Family Medicine — Payments: $4.9M
Family Medicine $4.9M
Donald Siao, Md, MD
Family Medicine — Payments: $22,670
Family Medicine $22,670
Minh Thai, Md, MD
Family Medicine — Payments: $21,268
Family Medicine $21,268
Dr. Linh Nguyen, D.o, D.O
Family Medicine — Payments: $18,110
Family Medicine $18,110
Trung Nguyen, M.d, M.D
Family Medicine — Payments: $16,169
Family Medicine $16,169
Dr. Shashwati Kale, M.d, M.D
Family Medicine — Payments: $11,410
Family Medicine $11,410